Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc.verified

CPHRF

Price:

$10.85

Market Cap:

$277.64M

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formul...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2006-02-02

Stock Exchange

PNK

Ticker

CPHRF

The PE Ratio as of November 2024 (TTM) for Cipher Pharmaceuticals Inc. (CPHRF) is 12.06

According to Cipher Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 12.06. This represents a change of 88.53% compared to the average of 6.40 of the last 4 quarters.

Cipher Pharmaceuticals Inc. (CPHRF) Historical PE Ratio (quarterly & annually)

How has CPHRF PE Ratio performed in the past?

The mean historical PE Ratio of Cipher Pharmaceuticals Inc. over the last ten years is 10.16. The current 12.06 PE Ratio has changed 11.77% with respect to the historical average. Over the past ten years (40 quarters), CPHRF's PE Ratio was at its highest in in the December 2014 quarter at 35.43. The PE Ratio was at its lowest in in the June 2015 quarter at -99.40.

Quarterly (TTM)
Annual

Average

10.16

Median

4.99

Minimum

-74.44

Maximum

68.64

Cipher Pharmaceuticals Inc. (CPHRF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cipher Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 175.73%

Maximum Annual PE Ratio = 68.64

Minimum Annual Increase = -1226.09%

Minimum Annual PE Ratio = -74.44

Quarterly (TTM)
Annual
YearPE RatioChange
20235.1493.04%
20222.66-44.92%
20214.8313.01%
20204.28-45.63%
20197.87-87.34%
201862.13175.73%
201722.53-1226.09%
2016-2.00-102.92%
201568.64-192.20%
2014-74.44-1067.04%

Cipher Pharmaceuticals Inc. (CPHRF) Average PE Ratio

How has CPHRF PE Ratio performed in the past?

The current PE Ratio of Cipher Pharmaceuticals Inc. (CPHRF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

4.21

5-year avg

4.96

10-year avg

10.16

Cipher Pharmaceuticals Inc. (CPHRF) PE Ratio vs. Peers

How is CPHRF’s PE Ratio compared to its peers?

Cipher Pharmaceuticals Inc.’s PE Ratio is greater than Bionoid Pharma Inc. (-507.70), greater than CENTR Brands Corp. (-1.38), greater than CTT Pharmaceutical Holdings, Inc. (-43.79), greater than Alterola Biotech, Inc. (-5.04), greater than Crescita Therapeutics Inc. (-4.06), less than Cannara Biotech Inc. (12.55), greater than Knight Therapeutics Inc. (-26.80), greater than Lowell Farms Inc. (-0.01), greater than Aion Therapeutic Inc. (-2.87), greater than HLS Therapeutics Inc. (-3.29), greater than Canntab Therapeutics Limited (-0.00),

Build a custom stock screener for Cipher Pharmaceuticals Inc. (CPHRF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cipher Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cipher Pharmaceuticals Inc. (CPHRF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cipher Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Cipher Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for Cipher Pharmaceuticals Inc. (CPHRF)?

What is the highest PE Ratio for Cipher Pharmaceuticals Inc. (CPHRF)?

What is the 3-year average PE Ratio for Cipher Pharmaceuticals Inc. (CPHRF)?

What is the 5-year average PE Ratio for Cipher Pharmaceuticals Inc. (CPHRF)?

How does the current PE Ratio for Cipher Pharmaceuticals Inc. (CPHRF) compare to its historical average?